| Followers | 19 |
| Posts | 6161 |
| Boards Moderated | 0 |
| Alias Born | 01/04/2012 |
Saturday, September 28, 2024 7:55:52 AM
It is getting harder and harder to hide the fact that ANIP is getting bought out.
Tezruly's Marketing Status was just discontinued. Marketing Start date was August 1, 2024. Even though, on September 24, 2024, they submitted the patent expiration info related to Tezruly, the first approved oral solution for an alpha -1 beta in the world with patent protection until January 18, 2041.
Discontinued
Tezruly Patent Protection
Prescribing details show Marketing Start Date
This explains why ANIP did not launch it.
Watch what they do, not what they say!
Tezruly's Marketing Status was just discontinued. Marketing Start date was August 1, 2024. Even though, on September 24, 2024, they submitted the patent expiration info related to Tezruly, the first approved oral solution for an alpha -1 beta in the world with patent protection until January 18, 2041.
Discontinued
Tezruly Patent Protection
Prescribing details show Marketing Start Date
This explains why ANIP did not launch it.
Watch what they do, not what they say!
Recent ANIP News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/13/2026 08:40:36 PM
- ANI Pharmaceuticals rolls out generic carbamazepine extended-release capsules • IH Market News • 04/13/2026 03:12:39 PM
- ANI Pharmaceuticals Announces the Launch of Carbamazepine Extended-Release Capsules • GlobeNewswire Inc. • 04/13/2026 10:50:00 AM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/09/2026 08:14:24 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/09/2026 08:13:29 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/09/2026 08:12:05 PM
- ANI Pharmaceuticals Announces FDA Approval and Launch of Isosorbide Mononitrate Tablet • GlobeNewswire Inc. • 04/08/2026 10:50:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 08:21:22 PM
- ANI Pharmaceuticals Announces Publication of NEW DAY Clinical Trial Results in Ophthalmology • GlobeNewswire Inc. • 04/07/2026 10:50:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/13/2026 09:28:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/13/2026 09:28:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/13/2026 09:28:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/10/2026 08:09:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/10/2026 08:09:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/10/2026 08:07:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/10/2026 08:06:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/10/2026 08:04:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 10:46:28 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/05/2026 10:22:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2026 11:46:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2026 11:45:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/03/2026 11:01:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/03/2026 12:05:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/02/2026 10:59:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/02/2026 10:59:32 PM
